Criterion for Assessing Accumulated Neurotoxicity of Alpha‐Synuclein Oligomers in Parkinson's Disease

Andrey KuznetsovInternational Journal for Numerical Methods in Biomedical Engineering 2025 · DOI

TL;DR

This paper introduces a novel metric, "accumulated neurotoxicity," to quantify the cumulative damage caused by alpha-synuclein (α-syn) oligomers in Parkinson's disease (PD). Their computational model suggests that the formation of Lewy bodies (LBs) might be neuroprotective by sequestering these toxic oligomers, and that impaired protein degradation pathways could significantly worsen PD progression.

What Problem Does This Paper Address?

Parkinson's disease is characterized by the degeneration of dopaminergic neurons and the presence of Lewy bodies (LBs), which are abnormal protein aggregates. While LBs were traditionally thought to be solely pathological, recent research suggests they might play a protective role by sequestering toxic α-synuclein (α-syn) oligomers. However, a clear understanding of how these oligomers contribute to neurotoxicity over time and how LB formation impacts this process has been lacking. This paper aims to address this gap by developing a quantitative criterion to assess accumulated neurotoxicity and to explore the factors influencing it, particularly the role of LB formation and protein degradation.

Methods

The authors developed a computational model to simulate the aggregation of α-synuclein and its impact on neuronal health. This model incorporates two main components:

  • LB Core Formation: A Finke-Watzky (F-W) model was used to simulate the aggregation of lipid membrane fragments and altered organelles, forming the core of the LB.
  • LB Halo Formation and α-Syn Aggregation: Another F-W model was adapted to simulate the formation of α-syn oligomers and their subsequent aggregation into fibrils, which constitute the halo of the LB.

The model tracks the concentrations of various species (monomers, free aggregates, deposited aggregates) and their dynamics over time. A key innovation is the introduction of a parameter called "accumulated neurotoxicity" (Ξ), defined as the time integral of the concentration of free α-syn oligomers. This metric aims to capture the cumulative damage to neurons. The study also performs sensitivity analyses to understand how different model parameters (e.g., rate constants, half-lives, production rates) influence accumulated neurotoxicity.

Datasets

Not discussed in the paper. The study relies on a computational model and parameter values estimated from existing literature.

Key Insights and Ideas

  • Accumulated Neurotoxicity as a Unified Metric: The introduction of Ξ provides a quantitative way to assess the overall neurotoxic burden over time, allowing for better comparison across different scenarios.
  • Lewy Bodies as Potential Neuroprotectors: The model suggests that rapid deposition of α-syn oligomers into LBs significantly reduces accumulated neurotoxicity, implying that LB formation might sequester toxic species and offer a protective effect.
  • Impaired Protein Degradation Worsens PD: Slower degradation of α-syn monomers and aggregates (longer half-lives) leads to increased accumulated neurotoxicity, supporting the hypothesis that compromised protein clearance pathways contribute to PD.
  • Sensitivity to Deposition Rate: Accumulated neurotoxicity is highly sensitive to the rate at which free α-syn aggregates deposit into fibrils (represented by the half-deposition time, $0_{1/2,B,AS}$). A transition from rapid deposition (low $0_{1/2,B,AS}$) to slow deposition (high $0_{1/2,B,AS}$) causes a sharp increase in neurotoxicity.
  • Autocatalytic Growth is Key: The autocatalytic rate constants ($k_2$) for α-syn aggregation have a greater impact on accumulated neurotoxicity than nucleation rate constants ($k_1$).

Key Results

  • The model predicts that accumulated neurotoxicity (Ξ) increases linearly with time when the concentration of free α-syn oligomers remains constant.
  • A critical threshold for accumulated neurotoxicity (estimated around $10^{10} \mu M \cdot s$) is proposed, beyond which neuron death is likely.
  • Simulations show that higher production rates of α-syn monomers ($q_{AS}$) and longer half-lives of α-syn monomers and aggregates ($T_{1/2,A,AS}$, $T_{1/2,B,AS}$) lead to significantly higher accumulated neurotoxicity, potentially exceeding the critical threshold.
  • Sensitivity analysis reveals sharp peaks in neurotoxicity when the half-deposition time of free α-syn aggregates into fibrils ($0_{1/2,B,AS}$) is in a specific transition range, highlighting the critical importance of efficient sequestration into LBs.

Limitations and Future Work

The authors acknowledge several limitations and suggest future directions:

  • Model Simplification: The current model treats free aggregates and oligomers interchangeably and does not explicitly model the release of α-syn oligomers from pre-formed fibrils. Future work could expand the model to include this "propagon" mechanism.
  • Transport of Aggregates: The model does not currently account for the transport of α-syn aggregates between neurons. Incorporating this aspect could provide a more comprehensive understanding of disease propagation.
  • Generalizability: While the accumulated toxicity parameter is presented in the context of PD, the authors suggest its potential application beyond neural domains.
  • Experimental Validation: The proposed critical neurotoxicity threshold requires validation through future experimental studies.
  • LB Composition: The model primarily focuses on α-syn fibrils in the LB halo, while recent findings suggest LBs are more complex structures containing lipid membranes and organelles. Future models could incorporate these complexities.

Summary updated

Abstract

The paper introduces a parameter called "accumulated neurotoxicity" of α-syn oligomers, which measures the cumulative damage these toxic species inflict on neurons over time, given the years it typically takes for such damage to manifest. A threshold value for accumulated neurotoxicity is estimated, beyond which neuron death is likely. Numerical results suggest that rapid deposition of α-syn oligomers into fibrils minimizes neurotoxicity, indicating that the formation of Lewy bodies might play a neuroprotective role. Strategies such as reducing α-syn monomer production or enhancing degradation can decrease accumulated neurotoxicity. In contrast, slower degradation (reflected by longer half-lives of monomers and free aggregates) increases neurotoxicity, supporting the idea that impaired protein degradation may contribute to Parkinson's disease progression. Accumulated neurotoxicity is highly sensitive to the half-deposition time of free α-syn aggregates into fibrils, exhibiting a sharp increase as it transitions from negligible to elevated levels, indicative of neural damage.
BibTeX
@article{kuznetsov2025criterion,
  author = {Andrey Kuznetsov},
  title = {{Criterion for Assessing Accumulated Neurotoxicity of Alpha‐Synuclein Oligomers in Parkinson's Disease}},
  journal = {International Journal for Numerical Methods in Biomedical Engineering},
  year = {2025},
  doi = {10.1002/cnm.70027},
}
Figure